Main articleEpileptic seizures triggered directly by focal transcranial magnetic stimulation
References (19)
- et al.
Clinical evaluation of conduction time measurements in central motor pathways using magnetic stimulation of human brain
Lancet
(1986) - et al.
Magnetic stimulation of the human brain: influence of size and shape of the stimulating coil
Safety of transcranial magnetic stimulation
Lancet
(1990)- et al.
Safety of rapid-rate transcranial magnetic stimulation in normal volunteers
Electroenceph. clin. Neurophysiol.
(1993) - et al.
Matching focal and non-focal magnetic coil stimulation to properties of the human nervous system: mapping motor unit fields in motor cortex contrasted with altering sequential digit movements by premotor SMA stimulation
- et al.
Magnetic stimulation of the human brain and peripheral nervous system: an introduction and the results of an initial clinical evaluation
Neurosurgery
(1987) - et al.
Transcranial magnetic stimulation in patients with epilepsy
Neurology
(1991) - et al.
Topographic organization of corticospinal projections from the frontal lobe: motor areas on the lateral surface of the hemisphere
J. Neurosci.
(1993) - et al.
Induction of seizures by transcranial magnetic stimulation in epileptic patients
J. Neurol.
(1991)
Cited by (84)
The impact of Transcranial Magnetic Stimulation (TMS) on seizure course in people with and without epilepsy
2022, Clinical Neurophysiology PracticeCitation Excerpt :Recent guidelines estimate a risk lower than < 0.03% of seizure induction during TMS (Wassermann, 1998; Schrader et al., 2004; Lerner et al., 2019; Chou et al., 2020); however, there are no systematic data on the effects of sp/ppTMS at the electrophysiological and clinical level. Most previous reports of seizure incidence in sp/ppTMS were anecdotal, presenting single events with inconclusive results and research parameters that may not meet current TMS research guidelines (Hömberg and Netz, 1989; Fauth et al., 1992; Classen et al., 1995; Michelucci et al., 1996; Haupts et al., 2004; Tharayil et al., 2005). Additionally, study design heterogeneity, small sample sizes and diversity of clinical profiles are all potential confounding factors that may influence risk estimation (Tremblay et al., 2019).
Seizure risk with repetitive TMS: Survey results from over a half-million treatment sessions
2021, Brain Stimulation